Previous page Next page

iEmoji Feeds @VJ Oncology (VJOncology)

1.

VJOncology
VJ Oncology @VJOncology
Updates by @apolo_andrea on IO in metastatic #bladdercancer:
Combo of chemo + IO did not work with atezo (PDL1)… twitter.com/i/web/status/1…
Retweet of status by @DrKarineTawagi
18 Feb 23 copy & paste +upvote -downvote Updates by @apolo_andrea on IO in metastatic #bladdercancer: ➡️ Combo of chemo + IO did not work with atezo (PDL1)… https://t.co/HxnsMPF2tt

2.

VJOncology
VJ Oncology @VJOncology
#GI23
Provocative and enjoyable session this morning on "Circulating Tumor DNA: Prime Time or Jumping Too Soon."… twitter.com/i/web/status/1…
Retweet of status by @PamelaKunzMD
21 Jan 23 copy & paste +upvote -downvote #GI23 🌟Provocative and enjoyable session this morning on "Circulating Tumor DNA: Prime Time or Jumping Too Soon."… https://t.co/gS3qry5hlQ
3.
VJOncology
VJ Oncology @VJOncology
off the press: phase 1b results of CAMILLA showing Cabo plus Durva is a safe, active, & potentially synergistic re… twitter.com/i/web/status/1…
Retweet of status by @AnwaarSaeed3
26 Jan 23 copy & paste +upvote -downvote 🔥off the press: phase 1b results of CAMILLA showing Cabo plus Durva is a safe, active, & potentially synergistic re… https://t.co/0ljLaJXhGM
4.
VJOncology
VJ Oncology @VJOncology
Results from a Phase I Trial - Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in P… twitter.com/i/web/status/1…
Retweet of status by @skopetz
09 Jan 23 copy & paste +upvote -downvote ⭐️👨‍⚕️Results from a Phase I Trial - Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in P… https://t.co/Ib4OFe4aZk
5.
VJOncology
VJ Oncology @VJOncology
Prostate cancer is one of the most common cancers found in men, with about 268,490 new cases of PC in the US in 20… twitter.com/i/web/status/1…
Retweet of status by @mjoshi916
30 Dec 22 copy & paste +upvote -downvote 💡Prostate cancer is one of the most common cancers found in men, with about 268,490 new cases of PC in the US in 20… https://t.co/R2FrDzWhyn
6.
VJOncology
VJ Oncology @VJOncology
#EMERALD elacestrant vs. endocrine therapy SOC (mostly fulvestrant) in terms of duration of prior CDK4/6:

Longer… twitter.com/i/web/status/1…
Retweet of status by @ErikaHamilton9
08 Dec 22 copy & paste +upvote -downvote #EMERALD elacestrant vs. endocrine therapy SOC (mostly fulvestrant) in terms of duration of prior CDK4/6: 🔆Longer… https://t.co/A5L9EAZNZ5
7.
VJOncology
VJ Oncology @VJOncology
️If you are a fellow, oncologist or work in the pharma industry and want to improve your oral communication skills… twitter.com/i/web/status/1…
Retweet of status by @drenriquegrande
13 Sep 22 copy & paste +upvote -downvote 🗣️If you are a fellow, oncologist or work in the pharma industry and want to improve your oral communication skills… https://t.co/KTf8bRhU1H
8.
VJOncology
VJ Oncology @VJOncology
Beautiful talk by Dr Fátima Cardoso while receiving the @myESMO Women for Oncology Award 2022
We should actively… twitter.com/i/web/status/1…
Retweet of status by @MarianaBrandao0
10 Sep 22 copy & paste +upvote -downvote Beautiful talk by Dr Fátima Cardoso while receiving the @myESMO Women for Oncology Award 2022 🙏 We should actively… https://t.co/SVH0m6468e
9.
VJOncology
VJ Oncology @VJOncology
How it started ? How its going ?
@CD_AACR @NatureMedicinetwitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
14 Aug 22 copy & paste +upvote -downvote 🎯How it started ? How its going ? @CD_AACR @NatureMedicine… https://t.co/tr62YH50O9
10.
VJOncology
VJ Oncology @VJOncology
That's a wrap on #EHA2022

Thank you to the organizers and everyone who came to speak to us

All our exclusive e… twitter.com/i/web/status/1…
Retweet of status by @VJHemOnc
13 Jun 22 copy & paste +upvote -downvote That's a wrap on #EHA2022 Thank you to the organizers and everyone who came to speak to us 🤩 All our exclusive e… https://t.co/EfiXUCOu6N
11.
VJOncology
VJ Oncology @VJOncology
star @ParseghianC discussing her trial personalizing MAPK targeted therapy strategies to #endcancer for EGFR rech… twitter.com/i/web/status/1…
Retweet of status by @VanMorrisMD
12 Jun 22 copy & paste +upvote -downvote 🌟 star @ParseghianC discussing her trial personalizing MAPK targeted therapy strategies to #endcancer for EGFR rech… https://t.co/JsYgOUzhvO

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
Previous page Next page
https://www.iemoji.com/feed/VJOncology
Back to top